Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-27 @ 5:37 PM
Study NCT ID:
NCT01361659
Status:
UNKNOWN
Last Update Posted:
2011-07-12
First Post:
2011-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Shockwave Treatment for Advanced Angina in Maastricht
Sponsor:
Maastricht University Medical Center
Organization:
Study Overview
Official Title:
Shockwave Treatment for Advanced Angina in Maastricht (SWAAM-study).
Status:
UNKNOWN
Status Verified Date:
2011-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SWAAM
Brief Summary:
There is an increasing number of patients with a coronary anatomy that does not allow additional revascularization procedures, while the patients suffer from angina pectoris at rest or at minimal exercise levels despite optimised medical therapy. There is a lack of therapeutic options for this group of so called "no-option patients". Goal of the project is to implement the shockwave therapy for no-option coronary artery disease patients and to evaluate its potential benefit on regional myocardial perfusion, on regional myocardial function and on the potential improvement in symptoms and quality of life.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: